Market Exclusive

Analyst Activity – Citigroup Initiates Coverage On NASDAQ:ONCE – Spark Therapeutics (NASDAQ:ONCE) With a Neutral

Analyst Ratings For NASDAQ:ONCE – Spark Therapeutics (NASDAQ:ONCE)

Today, Citigroup initiated coverage on NASDAQ:ONCE – Spark Therapeutics (NASDAQ:ONCE) with a Neutral with a price target of $85.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:ONCE – Spark Therapeutics (NASDAQ:ONCE)
NASDAQ:ONCE – Spark Therapeutics (NASDAQ:ONCE) has insider ownership of 5.90% and institutional ownership of 99.92%.

Recent Trading Activity for NASDAQ:ONCE – Spark Therapeutics (NASDAQ:ONCE)
Shares of NASDAQ:ONCE – Spark Therapeutics closed the previous trading session at 76.25 down -0.07 0.09% with 77.62999725341797 shares trading hands.

Exit mobile version